[Diagnosis and management in pediatric patients with ovarian masses]

C C Cabrera Chamorro1, C A Caicedo Paredes1, E A Portillo Bastidas1

  • 1Servicio de Cirugía Pediátrica. Fundación Hospital Infantil Los Ángeles. Pasto, Colombia.

Insights

In pediatric ovarian masses, large size, solid components, and positive tumor markers predict malignancy. Ovarian preservation is recommended for low-risk masses, while oophorectomy is for high-risk cases.

Area of Science:

  • Pediatric Surgery
  • Gynecologic Oncology
  • Pediatric Oncology

Background:

  • Ovarian masses are common in children, requiring careful diagnosis and management.
  • Distinguishing benign from malignant ovarian masses preoperatively is crucial for appropriate treatment planning.

Purpose of the Study:

  • To review the diagnosis and management of pediatric ovarian masses.
  • Identify preoperative risk factors for malignancy.
  • Evaluate surgical management strategies and outcomes.

Main Methods:

  • Retrospective study of pediatric patients (<18 years) surgically managed for ovarian masses.
  • Analysis of symptoms, imaging, tumor markers, treatment, outcomes, and pathology.
  • Primary endpoint: ovarian malignancy.

Main Results:

  • 54 patients identified (2014-2017); 49 benign, 5 malignant.
  • Malignant masses were larger (19.4 cm vs. 6.49 cm), had more solid components, and positive tumor markers.
  • Benign masses (43 patients) underwent ovarian preservation; malignant masses underwent oophorectomy and staging.

Conclusions:

  • Large size, solid components, and positive tumor markers predict malignancy in pediatric ovarian masses.
  • Ovarian preservation surgery is suitable for low-risk masses.
  • Oophorectomy with tumor staging is indicated for high-risk malignant ovarian tumors.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
264
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
311
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
233
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
301
Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis01:24

Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis

The nursing process provides a clinical decision-making framework for patients and families to establish and implement a personalized care plan. Since part of the nurse's duties is to teach patients, the steps of the nursing process are the most effective way to approach instruction. The nursing process and the teaching-learning process are inextricably linked.
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
2.5K
Nursing Diagnosis01:22

Nursing Diagnosis

Following assessment, a nursing diagnosis is the next step in the nursing process. It begins after the nurse has collected and recorded the patient data. The purpose of diagnosing is to identify how the client responds to actual or potential health processes, identify factors that bestow or that cause health problems, the etiologies, and identify resources or strengths the individual, group, or community can draw on to prevent or resolve problems.
The nursing diagnosis focuses on evidence-based...
4.1K